The FDA approved a polypill containing telmisartan, amlodipine, and indapamide, known as Widaplik, for the treatment of ...

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder ...

The FDA approved intravesical mitomycin in non–muscle-invasive bladder cancer as an nonsurgical alternative to transurethral ...

The FDA has approved a new antibiotic that can treat uncomplicated urinary tract infections, or uUTIs. It’s the first new class of oral antibiotics for UTIs in almost 30 years, according to developer ...

Treatment with retifanlimab plus carboplatin-paclitaxel statistically significantly reduced the risk of progression or death by 37% compared with placebo plus carboplatin-paclitaxel.

Three lots of a drug designed to treat various urinary tract infections have been recalled because the white round tablets might have black spots from microbial contamination.

Urinary tract infections are common and unpleasant, but a research team at Vanderbilt University has developed a ...

A drug commonly used in treatment for urinary tract infections may carry a risk of cancer, according to a recent study.

which evaluated Blujepa (gepotidacin), an oral antibiotic for treating uncomplicated urinary tract infections (uUTIs). This drug was recently approved by the FDA for uUTIs. In the past 60 days ...

Many women have, for decades, taken a drug called phenazopyridine to control pain from urinary tract infections. Sold under such brand names as Azo and Uristat, it’s available in most US ...

Please provide your email address to receive an email when new articles are posted on . New drugs for hypertension, UTIs and menopause symptoms are promising additions to the treatment ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ischemic stroke have been granted approval by the US Food and Drug ...